drugset / Trial / NCT04035785

Summary

To evaluate the efficacy and safety of Kangfu Xiaoyan Suppository in the treatment of pelvic inflammatory diseases (dampness-heat accumulation syndrome) and its influence on the sequelae of pelvic inflammatory diseases, and to study the role of traditional Chinese medicine in reducing the use of antibiotics and the risk of clinical medication, taking levofloxacin + metronidazole as the control drug.

Timeline

Start
2019-07-28
Primary completion
2019-07-28
Completion
2020-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Kangfu Anti-inflammatory Suppository Unknown — —